The Royal Adelaide Hospital, colloquially known by its initials or pronounced as "the Rah", is South Australia's largest hospital, owned by the state government as part of Australia's public health care system.

There are 800 beds in Royal Adelaide Hospital; Haematology Clinical Trials.

During the past decade, Royal Adelaide Hospital; Haematology Clinical Trials conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 3 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Adelaide Hospital; Haematology Clinical Trials" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator and "German CLL Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Royal Adelaide Hospital; Haematology Clinical Trials" are "Lymphocytic Leukemia, Chronic" (2 trials), "Acute Myeloid Leukemia" (1 trials), "Chronic Lymphocytic Leukemia" (1 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials) and "Hemophilia A" (1 trials). Many other conditions were trialed in "Royal Adelaide Hospital; Haematology Clinical Trials" in a lesser frequency.

Most popular intervention types in "Royal Adelaide Hospital; Haematology Clinical Trials" are "Drug" (10 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (3 trials), "Bendamustine" (2 trials), "Idasanutlin" (2 trials), "Obinutuzumab" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Royal Adelaide Hospital; Haematology Clinical Trials" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Royal Adelaide Hospital; Haematology Clinical Trials". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Royal Adelaide Hospital; Haematology Clinical Trials, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Adelaide Hospital; Haematology Clinical Trials, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".